MedPath

Glucometer and Mobile-phone Based Data Transfer System in Diabetes

Phase 4
Conditions
Diabetes
Registration Number
NCT02769377
Lead Sponsor
Taichung Veterans General Hospital
Brief Summary

To determine if glucometer combined with mobile-phone based data transfer system would be useful for patient diabetes to manage their glycemic control.

Detailed Description

Patients with diabetes who are advised by their providers to self-monitoring of blood glucose are eligible. Patients who decline or are not able to do self-monitoring of blood glucose will serve as controls.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. Patient with diabetes
  2. Patients' providers advised self-monitor of blood glucose
  3. Provided written informed consent.
Exclusion Criteria
  1. Patients had other medical condition that were considered not eligible by the medical team members

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
HbA1cHbA1c change from baseline at month 3 and 6
Secondary Outcome Measures
NameTimeMethod
Hypoglycemiaevent of hypoglycemia at month 3 and 6

Hypoglycemia was defined as a glucose value less than 70 mg/dl, or with typical symptoms of hypoglycemia. The information of hypoglycemia will be collected at each site visit (every 1-2 month).

Trial Locations

Locations (1)

Taichung Veterans General Hospital

🇨🇳

Taichung, Taiwan

Taichung Veterans General Hospital
🇨🇳Taichung, Taiwan
Wayne H Sheu, MD, PhD
Contact
886-4-23592525
whhsheu@vghtc.gov.tw
Jun-Sing Wang, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.